XML 40 R26.htm IDEA: XBRL DOCUMENT v3.22.0.1
Earnings Per Share
12 Months Ended
Dec. 31, 2021
Earnings Per Share [Abstract]  
EARNINGS PER SHARE EARNINGS PER SHARE
The following table sets forth the computation of the basic and diluted earnings per share of the Company's consolidated statements of operations for the years ended December 31, 2021, 2020 and 2019 (in thousands, except per share amounts): 
Year Ended December 31
202120202019
Earnings per common share - basic:
Numerator:
Net income$278,996 $238,114 $152,683 
Net income attributable to noncontrolling interests in CPLP(56)(315)(1,952)
Net income attributable to other noncontrolling interests(354)(521)(313)
          Net income available for common stockholders$278,586 $237,278 $150,418 
Denominator:
Weighted average common shares - basic148,666 148,277 128,060 
Net income per common share - basic$1.87 $1.60 $1.17 
Earnings per common share - diluted:
Numerator:
Net income$278,996 $238,114 $152,683 
Net income attributable to other noncontrolling interests(354)(521)(313)
Net income available for common stockholders before net income attributable to noncontrolling interests in CPLP$278,642 $237,593 $152,370 
Denominator:
Weighted average common shares - basic148,666 148,277 128,060 
     Add:
Potential dilutive common shares - stock options1 27 
Potential dilutive restrictive stock units - RSUs, less shares assumed purchased at market price199 54 — 
Weighted average units of CPLP convertible into common shares25 297 1,744 
Weighted average common shares - diluted148,891 148,636 129,831 
Net income per common share - diluted$1.87 $1.60 $1.17 
Anti-dilutive stock options represent stock options whose exercise price exceeds the average market value of the Company’s stock and are excluded from the calculation of diluted earnings per share. There were no anti-dilutive stock options for the years ended December 31, 2021, 2020, and 2019. The treasury stock method resulted in no dilution related to the forward contracts outstanding as of December 31, 2021 for the future sales of common stock under the Company's ATM program or from shares expected to be issued under the ESPP.